Constellation Brands
STZ
DexCom
DXCM
New Fortress Energy
NFE
Lantheus
LNTH
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
ARWR Arrowhead Pharmaceuticals
- 20.600
- +0.650+3.26%
Trading Feb 18 10:37 ET
2.60BMarket Cap-4.00P/E (TTM)
20.760High20.000Low232.49KVolume20.000Open19.950Pre Close4.75MTurnover0.21%Turnover RatioLossP/E (Static)126.10MShares36.72052wk High49.40P/B2.29BFloat Cap17.05052wk Low--Dividend TTM111.29MShs Float162.500Historical High--Div YieldTTM3.81%Amplitude1.200Historical Low20.445Avg Price1Lot Size
About Arrowhead Pharmaceuticals Company
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.
Company Profile
SymbolARWR
Company NameArrowhead Pharmaceuticals
Listing DateJun 16, 1993
Issue Price3.60
Founded1989
CEODr. Christopher Anzalone,PhD
MarketNASDAQ
Employees609
Fiscal Year Ends09-30
Address177 East Colorado Boulevard,Suite 700
CityPasadena
ProvinceCalifornia
CountryUnited States of America
Zip Code91105
Phone1-626-304-3400
Company Executives
- Name
- Position
- Salary
- Dr. Christopher Anzalone,PhD
- Chairman of the Board, Chief Executive Officer and President
- 12.42M
- Kenneth Myszkowski
- Chief Financial Officer and Principal Accounting Officer
- 3.51M
- Patrick C. O'Brien
- Chief Operating Officer, General Counsel and Corporate Secretary
- 3.93M
- Dr. Douglass Given, PhD
- Chairman of the Board
- 475.83K
- Douglas S. Ingram,Esq.
- Independent Director
- --
- Victoria Vakiener
- Independent Director
- 460.83K
- Dr. Michael S. Perry, PhD
- Independent Director
- 460.83K
- William D. Waddill
- Lead Independent Director
- 470.83K
- Dr. Mauro Ferrari, PhD
- Independent Director
- 460.83K
- Dr. Hongbo Lu, PhD
- Independent Director
- 424.17K
- Dr. Adeoye Olukotun, M.D.,M.P.H.
- Independent Director
- 460.83K
- James Hamilton
- Chief of Discovery and Translational Medicine
- 3.49M